Assessment of knowledge about Nutraceutical Regulations and practices among Nutraceutical manufacturer and Pharmacies
Abstract
Introduction: The Pakistani nutraceutical industry faces challenges in regulating its products due to insufficient knowledge among manufacturers and pharmacies, despite the Drug Regulatory Authority of Pakistan's 2014 regulations.
Objective: This study aims to assess the level of knowledge and practices regarding nutraceutical regulations among nutraceutical manufacturers and pharmacies in Pakistan. It explores the impact of regulatory practices on the manufacturing, sale, and quality of nutraceutical products.
Materials & Methods: A cross-sectional study was conducted involving 20 nutraceutical manufacturing units across Pakistan and 100 pharmacies and medical stores located in Lahore. Data were collected through a combination of online questionnaires and in-person interviews.
Results: 71.4% of nutraceutical manufacturers in Lahore demonstrated knowledge about the basic definition of nutraceuticals.92.9% of manufacturers in Lahore were aware of the purpose of SRO 412, which regulates herbal, Unani, homeopathic, and nutraceutical products. 64.3% of manufacturers in Lahore understood the significance of product stability during shelf life, while this knowledge was 100% in Peshawar and Islamabad. 90.4% of pharmacies had a pharmacist present, whereas 33.3% of medical stores did not have a pharmacist.74.1% of the pharmacies required prescriptions for nutraceutical sales when pharmacists were present, but only 27.4% of medical stores required prescriptions when pharmacists were absent.
Discussion: The findings highlight the gaps in regulatory knowledge and staff qualifications in the nutraceutical industry, which could compromise product safety and efficacy. Although some regulations are in place, enforcement and education are key issues. The absence of pharmacists in certain settings further complicates compliance with regulations, especially regarding product safety and labelling.
Conclusion: The study underscores the need for improved regulatory education and enforcement in Pakistan's nutraceutical sector. Enhanced training for manufacturers and pharmacies, coupled with stronger regulatory support from DRAP, is essential to ensure the safety and quality of nutraceutical products in the market.
Downloads
References
2. Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? Nature biotechnology. 1998;16(8):728-31.
3. Chan K. The historical evolution of Chinese medicine and orthodox medicine in China. The Way Forward for Chinese Medicine New York: Taylor & Francis. 2002:1-22.
4. Carmina D, Benfenati V, Simonelli C, Rotolo A, Cardano P, Grovale N, et al. Innovative solutions for disease management. Bioelectronic Medicine. 2023;9(1):28.
5. Hobbs JE, Malla S, Sogah EK. Regulatory frameworks for functional food and supplements. Canadian Journal of Agricultural Economics / Revue Canadienne d'Agroeconomie. 2014;62(4):569-94.
6. Mehmood S. Regulating the Pharmaceutical Industry: An Analysis of the Drug Regulatory Authority of Pakistan (DRAP); 2022.
7. Bank W. Pakistan Poverty Assessment. Poverty in Pakistan, Vulnerabilities, Social Gaps, and Rural Dynamics. South Asia Region; 2002.
8. Karim M, Mahmood M. Health systems in Pakistan: a descriptive analysis. Karachi, Pakistan: Department of Community Health Sciences, Aga Khan University; 1999.
9. Shaikh BT, Hatcher J. Complementary and alternative medicine in Pakistan: prospects and limitations. Evidence‐Based Complementary and Alternative Medicine. 2005;2(2):139-42.
10. Blaze J. A comparison of current regulatory frameworks for nutraceuticals in Australia, Canada, Japan, and the United States. Innovations in pharmacy. 2021;12(2).
11. Khan MMA, Sohail I, Alam I. Historical Evolution of Drug Laws in Pakistan: Regulating the Regulators and Healthcare Industry. Journal of the Punjab University Historical Society. 2020;33(02).
12. Malik, M., Hanif, Y., Hussain, A., & Hashmi, A. Exploring perceptions of regulators regarding factors affecting quality of nutraceuticals and cosmeceuticals: A qualitative study from Pakistan. International Journal of Health Sciences. 2023;7(S1):1910–1929. https://doi.org/10.53730/ijhs.v7nS1.14364.
13. Sharma G. Regulatory Guidelines for the Development of Plant/Phytochemical-Based Nutraceuticals. Formulations, Regulations, and Challenges of Nutraceuticals: Apple Academic Press; 2025. p. 171-91.
14. Noonan C, Noonan WP. Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients. Toxicology. 2006;221(1):4-8.
15. Ung COL, Harnett J, Hu H. Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience. BMC complementary and alternative medicine. 2017;17:1-17.
16. Al-Worafi YM. Herbal medicines safety issues. Drug safety in developing countries. ResearhGate; 2020 Jan. p. 163-78.
doi:10.1016/B978-0-12-819837-7.00014-5
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
